TechCrunch

DECEMBER 16, 2022

“While it may feel counterintuitive, given the recent market environment, the value of the equity for all parties — investors, founders and employees — is higher in the more conservative growth scenario,” says Mitchem. 6 investors discuss why AI is more than just a buzzword in biotech. Target audience/market size slide.

Biotech 215

Biotech Case Study Survey Study 215

N2Growth Blog

JANUARY 10, 2024

The Importance of Executive Search and Leadership Development to the Growth of the Life Sciences Industry Ensuring that organizations have access to top talent for key leadership positions and that talent is sufficiently supported and developed is critical to the growth of the life sciences industry.

Biotech 94

Biotech Leadership Recruiting Artificial Inteligence 94

TechCrunch

APRIL 8, 2022

. “Gogoro will use the fresh funds from its IPO to continue to expand in Taiwan as it branches outward to larger markets like China, India and Indonesia,” writes transportation reporter Rebecca Bellan. 6 questions investors should ask when evaluating psychedelic biotech companies. How can we support them?

Biotech 222

Biotech Windows Transportation Travel 222

CIO

APRIL 17, 2024

Normally, a CCO develops ideas about what the market needs and communicates them to a design team, which produces sketches to then be reviewed by the CCO. Helping software developers write and test code Similarly in tech, companies are currently open about some of their use cases, but protective of others.

Software Review 323

Software Review Enterprise Generative AI Artificial Inteligence 323

TechCrunch

JUNE 6, 2022

Zhavoronkov explained to TechCrunch that the last round “was very substantial and was intended to allow us to fund clinical development” and the company is “trying to be very conservative and careful with the money.” This presents an opportunity for Insilico Medicine to emerge as a winner during the biotech spring.”

Biotech 211

Biotech Artificial Intelligence Artificial Inteligence Pharmaceuticals 211

TechCrunch

OCTOBER 28, 2022

Reporter Dominic-Madori Davis moderated a discussion with Yin, Mike Asem (founding partner of M25), and Accel partner Rich Wong that elicited suggestions for early-stage founders who don’t live in the 415 area code and spilled the tea about “the emerging markets on their radars.”. 5 tips for launching in a crowded web3 gaming market.

Technical Review 228

Technical Review Software Review Development Team Review TDD 228

TechCrunch

APRIL 6, 2022

Navigating the choppy e-commerce seas : As reporter Ingrid Lunden writes, “e-commerce is synonymous with shopping on Amazon, but the reality is that a retailer has the option to use a bundle of different channels to sell and market products.” 6 questions investors should ask when evaluating psychedelic biotech companies. Big Tech Inc.

Marketing 235

Marketing Biotech Retail 3D 235

Crunchbase News

APRIL 19, 2024

Metsera , $290M, biotech: This week was a slower week than normal for biotech — as it was for most sectors — but that didn’t stop New York-based Metsera. The company develops power-optimized chips targeting the data analytics and generative AI markets. That’s still a lot of cash, but clearly round size trended down.

Biotech 102

Biotech Generative AI Artificial Intelligence Artificial Inteligence 102

TechCrunch

OCTOBER 27, 2021

Both the food ingredients and plant-based proteins markets are poised for steady growth. The global food ingredients market is forecasted to be valued at $400 billion by 2022, while plant-based foods are in line to be a $162 billion market by 2030. The biggest thing we need to do is produce a lot of ingredients,” Hume added.

Biotech 206

Biotech Sustainability Industry Marketing 206

TechCrunch

MAY 4, 2022

Previously relegated to underground communities and rave culture, drugs like ketamine, MDMA (commonly known as ecstasy) and psilocybin are now being studied to develop therapies to treat everything from PTSD to cluster headaches. But as public market sentiment fluctuates, specialized VCs seem more likely to stick around for the whole trip.

Marketing 235

Marketing Biotech Technical Review Weak Development Team 235

TechCrunch

JANUARY 10, 2023

German-based biotech company BioNTech — one of the big manufacturers of COVID-19 vaccines, among other things — is set to acquire InstaDeep , a Tunis-born and U.K.-based It gives brands a way to conduct market research and collect first-party data, which is important as marketers prepare for a post-cookie world. Ivan has more.

Trends 219

Trends Marketing ChatGPT Biotech 219

TechCrunch

AUGUST 3, 2021

Rani Therapeutics, a San Jose-based company developing a pill to replace medical injections, went public on Friday. . In 2020, 71 biotech companies went public. On July 30 alone, eight biotech companies were expected to begin trading, including Rani Therapeutics. . In an increasingly hot biotech market, protecting IP is key.

Biotech 245

Biotech Study .Net Systems Review 245

TechCrunch

JULY 20, 2021

Twitter Spaces: SaaS marketing with MKT1 founders Emily Kramer and Kathleen Estreich. In addition to their work with individual companies, they also run founder workshops, a job board and a marketer-led syndicate. In an increasingly hot biotech market, protecting IP is key. I hope you have a great week. Walter Thompson.

Marketing 132

Marketing Biotech Windows Company 132

Crunchbase News

MARCH 29, 2024

While there were no huge rounds like last week, money was again spread around from AI to biotech to marketing and more. Earlier in March, shares of Astera Labs — a developer of data center connectivity technology with use cases in generative AI — soared after its initial public offering on the Nasdaq.

Biotech 102

Biotech Artificial Intelligence Artificial Inteligence Energy 102

Crunchbase News

FEBRUARY 16, 2024

Not exactly sure what was in the water this week, but AI and biotech led the way as happens often. The startup is a provider of Nvidia ’s latest GPUs, which are highly sought after by AI developers. Freenome , $254M, biotech: This is just the first of many big biotech raises this week. billion valuation.

Lambda 91

Lambda Biotech Artificial Intelligence Artificial Inteligence 91

TechCrunch

JANUARY 3, 2023

The competition is not your market competitor or incumbent. More often, it is the investor’s set of operating heuristics, many of which are quickly influenced by market conditions. When markets start to dip, most companies hunker down and focus on surviving. Reframe the macro view. Get granular.

Healthcare 214

Healthcare Marketing Games Analysis 214

TechCrunch

DECEMBER 2, 2020

Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. We will be hiring more top notch AI researchers, software engineers, medicinal chemists and biotech talent, as well as building our own research labs.”

Biotech 265

Biotech 3D Artificial Inteligence Machine Learning 265

TechCrunch

MAY 12, 2023

If you look at the stock market, the view isn’t very good: the charts are all down and in the red, and all you can see are psychedelics companies tottering by, doing their best to impress cynical investors. The developments in Australia this year are extremely interesting and worth watching closely. Will they take the lead?”

Biotech 248

Biotech Survey Weak Development Team Systems Review 248

Crunchbase News

FEBRUARY 27, 2024

The drop in total dollars also meant Black-founded startups received their lowest share in the venture market since at least 2016, per Crunchbase. San Francisco-based Clerkie , developer of an AI financial planning tool for underserved Americans, raised a $33 million Series A led by Left Lane Capital. of the $140.4 of all U.S.

Marketing 132

Marketing Biotech Report Data 132

TechCrunch

AUGUST 18, 2022

But the cost and time involved in developing longevity solutions presents a major hurdle, which means founders must be prepared to take the long view. “It To get you up to speed on where the longevity market stands and where it’s headed, we spoke with: Samuel Gil , partner, JME Ventures.

Biotech 227

Biotech Survey Fintech Education 227

TechCrunch

DECEMBER 8, 2020

Boost Biomes , the Y Combinator-backed developer of microbiome-based bio-fungicides and bio-pesticides for agricultural applications, has added $2 million in funding and picked up a new strategic investor in Japan’s Universal Materials Incubator.

Biotech 168

Biotech Sustainability Applications Engineering 168

TechCrunch

NOVEMBER 22, 2022

million in a funding round led by Sequoia India and Southeast Asia’s Surge as it plans to expand the market for its medical imagery annotations solution. and Europe for marketing its tools. Healthtech startup RedBrick AI has raised $4.6 Artificial intelligence has become ubiquitous in clinical diagnosis.

Artificial Inteligence 234

Artificial Inteligence Artificial Intelligence Biotech 3D 234

TechCrunch

OCTOBER 11, 2022

The startup is attempting to position itself as being uniquely prepared to work with this market, and today it announced a $15 million seed investment on a post-money valuation of $100 million. He said he’s struggling to find women for his business development organization, but that’s something that he is actively working on.

Development 248

Development Pharmaceuticals Data Engineering Engineering 248

TechCrunch

MAY 26, 2021

So a new crop of biotech companies have worked to integrate these aspects. The money will go toward the requisite testing and paperwork involved in bringing a new drug to market based on promising leads. 2021 should be a banner year for biotech startups that make smart choices early.

Engineering 248

Engineering Biotech Chemicals Artificial Inteligence 248

TechCrunch

AUGUST 2, 2021

Planted appeared in 2019 as a spinoff from Swiss research university ETH Zurich, where the founders developed the original technique of extruding plant proteins and water into fibrous structures similar to real meat’s. The company plans to enter several new markets over Q3 and Q4, but the U.S.

Biotech 255

Biotech Technical Review Travel Course 255

TechCrunch

FEBRUARY 10, 2022

The pre-seed round was led by Latin America-focused biotech investor Zentynel Frontier Investments , with participation from academic incubation investors VentureWell , mission-driven impact investor ImpactAssets and a few additional angels from the United States and Latin America.

Biotech 199

Biotech Small Business Technology Leadership 199

TechCrunch

APRIL 13, 2022

Another important data point that connects both regions: the black market is a competitive factor. However, things are moving on the legal side of the market — it appears medical cannabis still carries most of the momentum, and it is only accelerating. Europe is largely a medical-only market right now. billion by 2026.

Marketing 246

Marketing Pharmaceuticals Research Insurance 246

TechCrunch

SEPTEMBER 17, 2021

Gingko’s market debut is one of the largest in biotech history. each this morning under the ticker DNA — biotech dieharders will recognize it as the former ticker used by Genentech. . Gingko aims to make money in two ways: first it contracts with manufacturers during the research and development phase (i.e.

Biotech 258

Biotech Sport Programming Company 258

Crunchbase News

JANUARY 26, 2024

The company — a utility-scale solar and energy storage project development, ownership and operations platform — will use the new capital to grow its “high value project development pipeline.” tied) Accent Therapeutics , $75M, biotech: Another week, another big biotech round.

Energy 86

Energy Biotech Pharmaceuticals Fintech 86

TechCrunch

APRIL 23, 2021

A biotech company that has spent 11 years researching supplements to increase human longevity plans to launch its supplements later this year. PayPal co-founder Peter Thiel invested in Unity Biotechnology , which is developing drugs to treat diseases that accompany aging. How and when to build marketing teams at deep tech companies.

Research 261

Research Biotech Nonprofit Comparison 261

TechCrunch

JULY 26, 2021

iRocket is earmarking $50 million over the next five years for the testing and development of its reusable engines and launch vehicle. Malik pointed out that the sale of Aerojet Rocketdyne to Lockheed Martin — which is still under review by the Federal Trade Commission — is going to leave a gap in the market.

Engineering 255

Engineering Testing Biotech 3D 255

TechCrunch

OCTOBER 20, 2022

It occurred to him that automation and robotics could make the drug development process more predictable, and so he founded Katakem , one of the startups in the TechCrunch Disrupt Battlefield 200. ” To Oliverio’s point, drug development today is a lengthy and expensive endeavor. . Food and Drug Administration. million ($1.27

Chemicals 211

Chemicals Development Course Sustainability 211

Crunchbase News

FEBRUARY 15, 2024

The venture market was down 38% last year as investors continued to reel back their funding with money becoming more expensive and liquidity options drying up. With its cash-intensive research and long product-to-market lead time, it usually is not attractive to investors in a down market where cash is king.

Biotech 92

Biotech Artificial Intelligence Artificial Inteligence Energy 92

TechCrunch

NOVEMBER 23, 2020

According to a statement, the company will invest heavily in developing new manufacturing technologies across cell and gene therapies, viral vectors, vaccines and proteins. billion to spend on sustainability and health-focused biotech. “It Flagship Pioneering raises $1.1

Pharmaceuticals 257

Pharmaceuticals Biotech Healthcare Sustainability 257

TechCrunch

MAY 15, 2023

Cambrian BioPharma is a new pharmaceutical startup with a revolutionary approach to developing and managing drug development age-related diseases. Now, with a valuation above $1 billion USD, Habi is a serious player in the LatAm home buying market, where the majority of the homes for sale are not listed online.

Pharmaceuticals 205

Pharmaceuticals Real Estate Biotech Games 205

Crunchbase News

FEBRUARY 2, 2024

The 40% valuation jump is even more impressive considering 2021 was a very different time in the private markets, with venture capital funding hitting all-time highs. Cour Pharmaceuticals , $105M, biotech: Chicago-based Cour Pharmaceuticals is the top biotech startup on the list this week. billion valuation.

Biotech 76

Biotech Artificial Intelligence Artificial Inteligence Pharmaceuticals 76

TechCrunch

JULY 23, 2021

Startups developing so-called deep tech often find it challenging to raise capital for various reasons. At TechCrunch Early Stage: Marketing and Fundraising, two experienced investors spoke on the subject and advised startups facing a challenging fundraising path.

Technical Advisors 254

Technical Advisors Biotech Hardware Applications 254